SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Vitalhub Corp. VHIBF OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • CA • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Vitalhub Corp. (VHIBF) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $5.90. It has a SharesGrow Score of 72/100, indicating a above average investment profile with 4 out of 7 criteria passed.

Financials: revenue is $109M, +40.2%/yr average growth. Net income is $6M, growing at +114.7%/yr. Net profit margin is 5.6% (thin). Gross margin is 70.2% (-12.2 pp trend).

Balance sheet: total debt is $3M against $266M equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 2.4 (strong liquidity). Debt-to-assets is 0.7%. Total assets: $352M.

Analyst outlook: 1 / 1 analysts rate VHIBF as buy (100%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 15/100 (Fail), Growth 100/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 43/100 (Fail), Future 100/100 (Pass), Income 45/100 (Partial).

VHIBF SharesGrow Score Overview

72/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 15/100

Valuation — P/E, PEG, Forward PEG

GROWTH 100/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 43/100

Gross margin is + market cap

FUTURE 100/100

Analyst outlook — as buy

INCOME 45/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — VHIBF

VHIBF trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

VHIBF: +40.2%/yr revenue is, +114.7%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

VHIBF: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet VHIBF: Debt-to-Equity (D/E) ratio 0.01 (conservative), Current ratio is 2.4 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

VHIBF: Gross margin is 70.2% (-12.2 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 43/100. ≥ 70 = Pass.

View details →

Analyst outlook: 1 / 1 analysts rate VHIBF as buy (100%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

VHIBF: Net profit margin is 5.6%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range4.883-10.582

Volume100

Avg Volume (30D)20.19K

Market Cap$373.07M

Beta (1Y)0.82

Share Statistics

EPS (TTM)0.10

Shares Outstanding$58.54M

IPO Date2021-04-09

Employees500

CEODaniel Paul Matlow

Financial Highlights & Ratios

Revenue (TTM)$108.88M

Gross Profit$76.44M

EBITDA$23.23M

Net Income$6.11M

Operating Income$12.16M

Total Cash$119.08M

Total Debt$2.51M

Net Debt$-55.07M

Total Assets$352.42M

Price / Earnings (P/E)59

Price / Sales (P/S)3.43

Analyst Forecast

Rating ConsensusBuy

Analysts Covering1

Buy 100% Hold 0% Sell 0%

Company Info

CountryCA

ExchangeOther OTC

CurrencyUSD

ISINCA92847V5018

Price Chart

VHIBF

Vitalhub Corp. ↗ · Other OTC

Healthcare • Medical - Healthcare Information Services

4.88 52WK RANGE 10.58

People Also View

Eli Lilly and Company

Johnson & Johnson

Roche Holding AG

Roche Holding AG

AstraZeneca PLC

Merck & Co., Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message